Wolters Kluwer Health has signed an agreement to acquire AgileMD, a healthcare technology company, for up to $100 million, of which $40 million is an upfront payment and the balance is a deferred consideration contingent upon reaching certain performance targets.
AgileMD provides AI-powered clinical decision support for health care professionals, offering them interactive clinical pathways and predictive analytics to enhance consistency in care and help them to reduce mortality rates. The company’s Pathways product operationalizes local guidelines in the EHR workflow for consistency in care and outcomes measurement. Its eCART solution is a real-time AI- powered clinical surveillance engine that is FDA1-cleared and designed to help reduce mortality rates.
“Combined with UpToDate Expert AI and our partnerships, AgileMD will serve as a vital enabler for true UpToDate ubiquity in healthcare – facilitating UpToDate’s expansion into embedded workflows, local guidelines, and new digital health applications,” said Yaw Fellin, Senior Vice President, Wolters Kluwer Clinical Solutions. “With AgileMD, we are well positioned to help healthcare systems provide better patient care and extract more value from their tech investments.”
Borna Safabakhsh, Co-Founder and CEO at AgileMD, commented, “We are excited to join Wolters Kluwer Health. Coupled with UpToDate, AgileMD can more fully deliver its transformative impact in critical decision support workflows. Leveraging UpToDate’s foundational capabilities, AgileMD will accelerate and streamline the development and maintenance of more advanced clinical pathways for complex clinical decision-making support.”
Since its introduction in September 2025, UpToDate Expert AI has been adopted by more than 2,700 U.S. hospitals and health systems, representing more than 95% of U.S.-based UpToDate Enterprise Edition customers.
Additional information and financial terms
AgileMD, based in San Francisco, was founded in 2011 and is currently led by co-founders Borna Safabakhsh and Dana Edelson, M.D., Chief Medical Officer. All 23 employees will be joining Wolters Kluwer Health. AgileMD has seen strong growth and is expected to reach annual recurring revenues (ARR) of $7 million by year-end 2026. The acquisition is expected to achieve a return on invested capital (ROIC) at or above our after-tax weighted average cost of capital (WACC) of 8% within 3-5 years and to have an immaterial impact on Wolters Kluwer adjusted earnings. The transaction, which is subject to customary closing conditions and other governmental approvals, is expected to close in the first quarter of 2027 or sooner.